Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury
- 1 March 1997
- journal article
- Published by Elsevier in Brain Research
- Vol. 752 (1-2) , 301-306
- https://doi.org/10.1016/s0006-8993(96)01488-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro: inhibition of a proteinase (calpain) prevents myelin and cytoskeletal protein degradationBrain Research, 1997
- Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration.Stroke, 1994
- A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord InjuryNew England Journal of Medicine, 1990
- Purification of calcium-activated neutral proteinase (CANP) from purified myelin of bovine brain white matterNeurochemical Research, 1988
- The breakdown of the individual neurofilament proteins by cathepsin DNeurochemical Research, 1987
- Proteolytic enzymes in experimental spinal cord injuryJournal of the Neurological Sciences, 1986
- Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolismJournal of Neurosurgery, 1984
- Degradation of cytoskeletal proteins in experimental spinal cord injuryNeurochemical Research, 1982
- The Effects of Spinal Cord Trauma on MyelinJournal of Neuropathology and Experimental Neurology, 1980
- REMARKS ON THE HISTOPATHOLOGICAL CHANGES IN THE SPINAL CORD DUE TO IMPACT. AN EXPERIMENTAL STUDYJournal of Nervous & Mental Disease, 1914